SB 31 Colorado Senate · 2026 Regular Session

Use of Prescription Product with Controlled Substance

Summary
The act exempts from schedule I a prescription drug product containing a schedule I controlled substance (product) if the product is:Approved for prescription use by the United States food and drug administration;Designated or rescheduled by the United States drug enforcement agency (DEA); Dispensed by a pharmacy or prescription drug outlet, or administered by an authorized practitioner; andPossessed by a person who is authorized to possess a controlled substance.     The exemption applies upon the DEA's designation or rescheduling.     The act requires that the product be controlled in Colorado in the same manner as the product is controlled by the DEA and state law.     The act clarifies that its provisions do not apply to or affect the regulation of or lawful actions or conduct concerning natural medicine, natural medicine product, marijuana, or marijuana concentrate.(Note: This summary applies to this bill as enacted.)
Bill status signed all 5 stages cleared
Introduction
Jan 2026
Committee Review
Mar 2026
Senate Passage
Apr 2026
House Passage
Apr 2026
Signed into Law
Apr 2026
Introduced Jan 22, 2026 Signed Apr 20, 2026
Maddy AI version diff · 5 comparisons

What changed between versions

Rerevised Final Act · 3 edits · Apr 7, 2026
MINOR
The bill was finalized and prepared for signature, adding a note to indicate its status for legislative officers and the Governor. The core text remains substantively identical to the previous version, establishing a legal framework for the lawful use of prescription drugs containing Schedule I controlled substances in Colorado.
Scope change
The bill's scope remains unchanged; it continues to exempt specific prescription drugs containing Schedule I substances from state prohibition if they meet federal approval and dispensing requirements.
TECHNICAL

Added a note at the beginning of the document stating that the bill is prepared for signatures and directing readers to legislative status sheets for the Governor's action.

Updated the header information to reflect the 'Final Act' status, including the date of the 3rd Reading Unamended (April 2, 2026) and the signatures of the President of the Senate, Speaker of the House, Chief Clerk, and the Governor.

Adjusted the bill summary section to remove language indicating the summary was preliminary, as the bill has now passed all readings and been enacted.

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
16
Key actions
8
Committee
3
Amendments
1
Apr 20, 2026
Signed into law
Governor Signed
executive
Apr 7, 2026
Lower · Passed
Signed by the Speaker of the House
lower
Apr 7, 2026
Upper · Passed
Signed by the President of the Senate
upper
Apr 6, 2026
Introduced
Senate Considered House Amendments - Result was to Concur - Repass
upper
Apr 2, 2026
Lower · Passed
House Third Reading Passed - No Amendments
lower
Mar 25, 2026
Lower · Passed
House Committee on Health & Human Services Refer Amended to House Committee of the Whole
lower
Feb 25, 2026
Introduced
Introduced In House - Assigned to Health & Human Services
lower
Feb 24, 2026
Upper · Passed
Senate Third Reading Passed - No Amendments
upper
Feb 12, 2026
Upper · Passed
Senate Committee on Health & Human Services Refer Amended to Senate Committee of the Whole
upper
Feb 4, 2026
Upper · Passed
Senate Committee on Health & Human Services Witness Testimony and/or Committee Discussion Only
upper
Jan 22, 2026
Introduced
Introduced In Senate - Assigned to Health & Human Services
upper
4 primary · 13 co-sponsors

Sponsors